EP2242772
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2008EP published:
26.11.2014EP application number:
08865838.0
EPO information:
European Patent Register
Max expiry date:
22.12.2028
Title:
IMMUNOCONJUGATES TARGETING CD138 AND USES THEREOF
Timeline
Today
23.12.2008EP application
26.11.2014EP Publication
Owner
Name:
Biotest AGAddress:
Landsteinerstr. 5, 63303, Dreieich, DE
Name:
Immunogen, Inc.Address:
830 Winter Street, 02451-1477, Waltham, MA, US
Inventor
Name:
KRAUS, ElmarAddress:
Bad Vilbel, DE
Name:
BRUECHER, ChristophAddress:
Eschborn, DE
Name:
DAELKEN, BenjaminAddress:
Frankfurt am Main, DE
Name:
ZENG, SteffenAddress:
Münster, DE
Name:
OSTERROTH, FrankAddress:
Dietzenbach, DE
Name:
UHEREK, ChristophAddress:
Seligenstadt, DE
Name:
AIGNER, SilkeAddress:
Frankenthal, DE
Name:
GERMER, MatthiasAddress:
Langen, DE
Name:
SCHULZ, GregorAddress:
Umkirch, DE
Name:
HAEDER, ThomasAddress:
Dreieich, DE
Priority
Number:
16620 PDate:
26.12.2007Country:
US
Number:
87466 PDate:
8.8.2008Country:
US
Number:
87590 PDate:
8.8.2008Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, A61P 35/00, A61K 47/48, A61K 39/395